HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility

Oncology Letters

Volumn 4, Issue 2, 2012, Pages 358-364

  Li, Yuchun ^a   Wang, Kaijuan ^a   Dai, Liping ^a   Wang, Peng ^a   Song, Chunhua ^a   Shi, Jianxiang ^a   Ren, Pengfei ^a   Ye, Hua ^a   Zhang, Jianying ^a,b  

^a ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

CIP2A; HapMap; Hepatocellular carcinoma; Polymorphism

Indexed keywords

ONCOPROTEIN; PROTEIN CIP2A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DRINKING BEHAVIOR; ETHNICITY; FAMILY HISTORY; FEMALE; GENDER; GENE FREQUENCY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84861993165     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.728     Document Type: Article

References (31)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 1329: 2557-2576, 2007.
2. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma: Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol 25: 657-663, 2010.
3. International Agency for Research on Cancer: GLOBOCAN 2008. Geneva: WHO. Available at http://www-dep.iarc.fr/.
4. Mori M, Hara M, Wada I, Hara I, Yamamoto K, Honda M and Naramoto J: Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 151: 131-139, 2000.
5. Yuan JM, Govindarajan S, Arakawa K and Yu MC: Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 101: 1009-1017, 2004.
6. Jee SH, Ohrr H, Sull JW and Samet JM: Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96: 1851-1856, 2004.
7. Kuper H, Tzonou A, Kaklamani E, et al: Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85: 498-502, 2000.
8. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL and LokAS: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42: 218-224, 2005.
9. Zhang JY, Dai M, Wang X, et al: A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol 27: 574-578, 1998.
10. Zhang JY, Wang X, Han SG and Zhuang H: A case-control study of risk factors for hepatocellular carcinoma in Henan, China. Am J Trop Med Hyg 59: 947-951, 1998.
11. Budhu A and Wang XW: The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 80: 1197-1213, 2006.
12. Giacalone A, Montalto G, Giannitrapani L, et al: Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. OMICS 15: 193-196, 2011.
13. Li S, Deng Y, Chen ZP, et al: Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol 11: 2083-2088, 2011.
14. Chinen MH, Yeh CB, Li YC, et al: Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol 104: 798-803, 2011.
15. Sümbül AT, Akkiz H, Bayram S, Bekar A, Akqöllü E and Sandi{dotless}kçi{dotless} M: p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep 39: 1639-1647, 2012.
16. Chakravarti A: Population genetics-making sense out of sequence. Nat Genet 21: 56-60, 1999.
17. Ikeda M, Iwata N, Kitajima T, Suzuki T, Yamanouchi Y, Kinoshita Y and Ozaki N: Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology 31: 866-871, 2006.
18. The International HapMap Consortium: A haplotype map of the human genome. Nature 437: 1299-1320, 2005.
19. International HapMap Consortium, Frazer KA, BallinqerDG, et al: A second generation human haplotype map of over 3.1million SNPs. Nature 449: 851-861, 2007.
20. de Bakker PI, Burtt NP, Graham RR, et al: Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet 38: 1298-1303, 2006.
21. Soo Hoo L, Zhang JY and Chan EK: Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 21: 5006-5015, 2002.
22. Zhang JY, Wang X, Peng XX and Chan EK: Autoantibody responses in Chinese hepatocellular carcinoma. J Clin Immunol 22: 98-105, 2002.
23. Junttila MR, Puustinen P, Niemelä M, et al: CIP2A inhibits PP2A in human malignancies. Cell 130: 51-62, 2007.
24. Ye S, Dhillon S, Ke X, Collins AR and Dav IN: An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29: E88-8, 2001.
25. Little S: Amplification-refractory mutation system (ARMS) analysis of point mutations. Curr Protoc Hum Genet Chapter 9: Unit 9.8, 2001.
26. Rothman KJ: The estimation of synergy or antagonism. Am J Epidemiol 103: 506-511, 1976.
27. Han W, Kang D, Lee JE, et al: A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Clin Cancer Res 11: 4775-4778, 2005.
28. Hu Z, Xu L, Shao M, et al: Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Cancer Epidemiol Biomarkers Prev 15: 1336-1340, 2006.
29. Kirk GD, Bah E and Montesano R: Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 27: 2070-2082, 2006.
30. Brechot C, Kremsdorf D, Soussan P, Pineau P, Dejean A, Paterlini-Brechot P and Tiollais P: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. Pathol Biol (Paris) 58: 278-287, 2010.
31. Koike K: Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol 22: S108-S111, 2007.